INTEGRITES has successfully defended Farmak in the case related to abuse of monopoly position by Pharmhim LTD News/Projects
All news

INTEGRITES has successfully defended the interests of Farmak Public Joint Stock Company (PJSC Farmak), a leading pharmaceutical firm in Ukraine, in the exclusive and complex case regarding the abuse of dominant position on the national market of medical substances used for the production of completed pharmaceutical products.

This project is absolutely unique because the Antimonopoly Committee of Ukraine (Ukrainian competition authority) for the first time has conducted such an investigation of the abusive actions committed by the monopolist, specifically in respect to the medical substance Mebhydrolin that is used by many members of the pharmaceutical market, including PJSC Farmak.

In the course of this case, Antitrust & Competition practice of INTEGRITES, consisting of Vyacheslav Korchev (Senior Partner), Serhiy Shershun (Counsel) and Bohdan Ilchenko (Associate) implemented a comprehensive legal strategy intended to protect PJSC Farmak’s interests based on the fact that Pharmhim Limited Liability Company (LLC Pharmhim) partly refused to supply Mebhydrolin, medical substance that was actively used by PJSC Farmak in order to produce its well-known pharmaceutical product – Diazolin®.

Antitrust & Competition practice of INTEGRITES faced with a number of complicated issues during the investigation. Nevertheless, we have managed to provide the legal support to PJSC Farmak to prove the AMCU that the medical substance Mebhydrolin could not be replaced with any other medical substance for the production of Diazolin®. In fact, there was no alternative supplier on the pharmaceutical market at that time and therefore, LLC Pharmhim abused its monopoly position towards PJSC Farmak. In addition, we calculated the number of losses caused by the anticompetitive actions of LLC Pharmhim.

As a result of the professional legal assistance provided by INTEGRITES, the Antimonopoly Committee of Ukraine on August 16, 2018, defended the interests of PJSC Farmak by imposing a fine on LLC Pharmhim for the competition violation.

Эта запись также доступна на: Russian, Ukrainian

Latest news
Serhiy Shershun promoted to partner at INTEGRITES
INTEGRITES announces the appointment of Serhiy Shershun, Counsel and Head of Antitrust and Competition, as Partner effective from January 1, 2020. Following this promotion, the leadership board at INTEGRITES in Ukraine has grown to 11 partners….

Эта запись также доступна на: Russian, Ukrainian

More details
INTEGRITES succeeds in GAFTA arbitration in favour of the Swiss agricultural commodity trader
INTEGRITES successfully represented interests of Swiss Sellers as Claimant in a London-seated GAFTA arbitration against Swiss Buyers as Respondent concerning the violation of the terms of the contract for the sale of corn of Ukrainian origin. The…

Эта запись также доступна на: Russian, Ukrainian

More details
INTEGRITES becomes the only law firm in Ukraine with two experts recognized by WWL: Arbitration 2020
INTEGRITES becomes the only Ukrainian law firm to receive recognition of two arbitration experts out of eight representing Ukraine in the international guide Who’s Who Legal: Arbitration 2020. The recently published edition of the guide…

Эта запись также доступна на: Russian, Ukrainian

More details
See all
Subscribe to the newsletter